QHP Capital, the management company for NovaQuest Private Equity, has acquired Lexitas Pharma Services, an ophthalmology contract research organization.
Lexitas provides clinical trial and medical strategy services to biopharmaceutical firms.
“For the past decade, Lexitas has had the incredible opportunity and privilege to partner with talented companies with amazing science as they develop their ophthalmic drugs and devices. Partnering with the QHP team brings deep expertise and domain knowledge that is going to allow Lexitas to improve and increase the scope, quality, and efficiency of our capabilities. We couldn’t be more thrilled to be working with QHP and are excited at the prospect of getting safe and efficacious ophthalmic drugs to patients efficiently and quickly,” said George Magrath, CEO of Lexitas.